Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd. faced a significant decline in stock value on October 13, 2025, reaching an intraday low. Despite this, the company has shown resilience with substantial long-term performance increases over three and five years, alongside a solid return on equity and favorable valuation metrics.

Jiangsu Nhwa Pharmaceutical Co., Ltd. faced a significant stock decline on September 30, 2025, reaching an intraday low. Despite a positive monthly performance and increased profits over the past year, the stock has struggled, reflecting challenges in the current trading environment. The company maintains solid financial metrics.

Jiangsu Nhwa Pharmaceutical Co., Ltd. saw a decline in stock value today, contrasting with the broader market's smaller decrease. Despite this, the company has shown resilience over the past week and month. Financial metrics indicate solid valuation and a dividend yield, highlighting its attractiveness in the sector.